ID   F-36E
AC   CVCL_7227
SY   F36E; F-36EGM; F-36-EGM; F36EGM
DR   CLO; CLO_0051545
DR   BioSample; SAMN03472229
DR   Cell_Model_Passport; SIDM01625
DR   Cosmic; 787429
DR   Cosmic; 919126
DR   Cosmic; 1281312
DR   RCB; RCB0776
DR   Wikidata; Q54833026
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1834251;
RX   PubMed=9510473;
CC   Population: Japanese.
CC   Characteristics: EPO dependent.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0776
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2037 ! F-36P
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1834251; DOI=10.1182/blood.V78.9.2261.2261;
RA   Chiba S., Takaku F., Tange T., Shibuya K., Misawa C., Sasaki K.,
RA   Miyagawa K., Yazaki Y., Hirai H.;
RT   "Establishment and erythroid differentiation of a cytokine-dependent
RT   human leukemic cell line F-36: a parental line requiring
RT   granulocyte-macrophage colony-stimulating factor or interleukin-3, and
RT   a subline requiring erythropoietin.";
RL   Blood 78:2261-2268(1991).
//
RX   PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x;
RA   Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y.,
RA   Hirai H.;
RT   "Frameshift mutations of the hMSH6 gene in human leukemia cell
RT   lines.";
RL   Jpn. J. Cancer Res. 89:33-39(1998).
//